This study was supported by a grant from the National Natural Science Foundation of China (No. 30670868) and the Provincial Natural Science Foundation of Zhejiang (No. R206007).
Background Mesenchymal stem cells are a promising cell type for cell transplantation in myocardial infarction. Type I neuregulins-1, also known as heregulin, can promote the survival of cardiomyocytes and stimulate an...